-
Epic Greaves double ton earns West Indies draw in first NZ Test
-
Thunder roll to 14th straight NBA win, Celtics beat depleted Lakers
-
Myanmar citizens head to early polls in Bangkok
-
Starvation fears as more heavy rain threaten flood-ruined Indonesia
-
Sri Lanka unveils cyclone aid plan as rains persist
-
Avatar 3 aims to become end-of-year blockbuster
-
Contenders plot path to 2026 World Cup glory after Trump steals show at draw
-
Greaves leads dramatic West Indies run chase in NZ Test nail-biter
-
World record-holders Walsh, Smith grab wins at US Open
-
Ukraine, US to meet for third day, agree 'real progress' depends on Russia
-
Double wicket strike as New Zealand eye victory over West Indies
-
New Memoir In Pursuit of Glory Exposes the High-Stakes Journey to from Laborer to Executive Leadership in a Male-Dominated Industry
-
Peace medal and YMCA: Trump steals the show at World Cup draw
-
NBA legend Jordan in court as NASCAR anti-trust case begins
-
How coaches reacted to 2026 World Cup draw
-
Glasgow down Sale as Stomers win at Bayonne in Champions Cup
-
Trump takes aim at Europe in new security strategy
-
Witness in South Africa justice-system crimes probe shot dead
-
Tuchel urges England not to get carried away plotting route to World Cup glory
-
Russian ambassador slams EU frozen assets plan for Ukraine
-
2026 World Cup draw is kind to favorites as Trump takes limelight
-
WHO chief upbeat on missing piece of pandemic treaty
-
US vaccine panel upends hepatitis B advice in latest Trump-era shift
-
Ancelotti says Brazil have 'difficult' World Cup group with Morocco
-
Kriecmayr wins weather-disrupted Beaver Creek super-G
-
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
-
Mixed day for global stocks as market digest huge Netflix deal
-
Fighting erupts in DR Congo a day after peace deal signed
-
England boss Tuchel wary of 'surprise' in World Cup draw
-
10 university students die in Peru restaurant fire
-
'Sinners' tops Critics Choice nominations
-
Netflix's Warner Bros. acquisition sparks backlash
-
France probes mystery drone flight over nuclear sub base
-
Frank Gehry: five key works
-
US Supreme Court to weigh Trump bid to end birthright citizenship
-
Frank Gehry, master architect with a flair for drama, dead at 96
-
'It doesn't make sense': Trump wants to rename American football
-
A day after peace accord signed, shelling forces DRC locals to flee
-
Draw for 2026 World Cup kind to favorites as Trump takes center stage
-
Netflix to buy Warner Bros. in deal of the decade
-
US sanctions equate us with drug traffickers: ICC dep. prosecutor
-
Migration and crime fears loom over Chile's presidential runoff
-
French officer charged after police fracture woman's skull
-
Fresh data show US consumers still strained by inflation
-
Eurovision reels from boycotts over Israel
-
Trump takes centre stage as 2026 World Cup draw takes place
-
Trump all smiles as he wins FIFA's new peace prize
-
US panel votes to end recommending all newborns receive hepatitis B vaccine
-
Title favourite Norris reflects on 'positive' Abu Dhabi practice
-
Stocks consolidate as US inflation worries undermine Fed rate hopes
| RBGPF | 0% | 78.35 | $ | |
| GSK | -0.33% | 48.41 | $ | |
| VOD | -1.31% | 12.47 | $ | |
| NGG | -0.66% | 75.41 | $ | |
| RELX | -0.55% | 40.32 | $ | |
| AZN | 0.17% | 90.18 | $ | |
| BTI | -1.81% | 57.01 | $ | |
| BP | -3.91% | 35.83 | $ | |
| RYCEF | -0.34% | 14.62 | $ | |
| CMSC | -0.21% | 23.43 | $ | |
| RIO | -0.92% | 73.06 | $ | |
| BCC | -1.66% | 73.05 | $ | |
| JRI | 0.29% | 13.79 | $ | |
| SCS | -0.56% | 16.14 | $ | |
| CMSD | -0.3% | 23.25 | $ | |
| BCE | 1.4% | 23.55 | $ |
Many dementia cases could be prevented, but far from all: study
Millions of cases of dementia could be prevented or delayed by reducing a range of risk factors such as smoking or air pollution, according to a major new study, though outside experts warn that such measures can only go so far.
The debilitating condition, which progressively robs people of their memories, cognitive abilities, language and independence, currently affects more than 55 million people across the world.
Dementia is caused by a range of diseases, the most common of which is Alzheimer's.
A huge review of the available evidence published in The Lancet journal on Wednesday said that the "potential for prevention is high" in the fight against dementia.
The study follows a previous report in 2020 that also emphasised the importance of prevention.
At the time, the international team of researchers estimated that 40 percent of dementia cases were linked to 12 risk factors.
The factors included people having a lower level of education, hearing problems, high blood pressure, smoking, obesity, depression, physical inactivity, diabetes, excessive drinking, traumatic brain injury, air pollution and social isolation.
The latest update adds two more risk factors: vision loss and high cholesterol.
"Nearly half of dementias could theoretically be prevented by eliminating these 14 risk factors," the study said.
- EU turns down new drug -
Decades of research and billions of dollars have failed to produce a cure or truly effective drug for dementia.
But since the start of last year, two Alzheimer's treatments have been approved in the United States: Biogen's lecanemab and Eli Lilly's donanemab.
They work by targeting the build-up of two proteins -- tau and amyloid beta -- considered to be one of the main ways the disease progresses.
However, the benefits of the drugs remain modest, they have severe side effects, and they are often very expensive.
In contrast to the US, the European Union's medicine watchdog last week refused to approve lecanemab, and it is still considering donanemab.
Some researchers hope the fact that the new drugs work at all means they will pave the way for more effective treatments in the future.
Others prefer to focus on ways to prevent dementia in the first place.
Masud Husain, a neurologist at the UK's University of Oxford, said that focusing on risk factors "would be far more cost effective than developing high-tech treatments which so far have been disappointing in their impacts on people with established dementia".
- 'How much more could we do?' -
The Lancet study was welcomed by experts in the field, among whom the importance of prevention is hardly debatable.
However, some said the idea that nearly half of all dementia cases could be prevented should be put in perspective.
It has not been proven that the risk factors directly cause dementia, as the authors of the study acknowledged.
For example, could it be dementia that is causing depression, rather than the other way around?
It is also difficult to separate the risk factors from each other, though the researchers tried.
Some could be intrinsically linked, such as depression and isolation, or smoking and high blood pressure.
Above all, many of the risk factors are societal scourges that have long proven near impossible to fully address.
The study lays out different recommendations ranging from the personal -- such as wearing a helmet while cycling -- to governmental, such as improving access to education.
"It is not clear whether we could ever completely eliminate any of these risk factors," Charles Marshall, a neurologist at Queen Mary University of London, told AFP.
"We already have public health programmes to reduce smoking and hypertension (high blood pressure), so how much more could we do?"
Tara Spires-Jones, a neuroscientist at the University of Edinburgh, said it was important that "we do not blame people living with dementia for their brain disease".
That is because "it is clear that a large portion of dementias could not be prevented due to genes and things beyond people's control, like opportunities for education as children", she added.
S.Jackson--AT